Praxis Precision Medicines Inc (PRAX) saw downtrend of -0.98% in the recent trading with $45.54 being its most recent. The current price level -50.41% lower than the highest price of $91.83 marked by the stock while trading over the past 52-weeks, whereas it is 70.56% higher than the lowest price of $26.70 the company dropped to over past 52-weeks. The latest news story on PRAX appeared in (GlobeNewswire) under the title “Praxis Precision Medicines to Participate in Upcoming Fireside Chat”.
Squeezing the time span to 30 day period shows us the stock is currently trading -23.17% below one month high and is +3.15% above of the lowest during that time. Looking into the simple moving average, Praxis Precision Medicines Inc (PRAX)’s stock stands at a SMA-50 of $49.08 while that of 5-day is reading $46.66.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and PRAX’s SMA-200 as of now is $54.41.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent perfor mance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 5 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperfor m, the score of 3 means hold, and the score of 4 indicates underperfor m. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.42 for the stock.
Praxis Precision Medicines Inc Earnings – What Happened With PRAX
Coming around sales and income figures on PRAX Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Praxis Precision Medicines Inc (PRAX) last released financial results for the quarter that ended 9/30/2024, posting a surprise factor of -40.94% for net revenue.
PRAX – Praxis Precision Medicines Inc Stock Earnings Estimates
The perspective of Praxis Precision Medicines Inc (NASDAQ:PRAX)’s current quarter earnings identifies that analysts are in consensus over the estimate of -1.95 for stock’s EPS in the current quarter. Praxis Precision Medicines Inc (PRAX) last released financial results for the quarter that ended 9/30/2024, posting a surprise factor of -40.94% for net revenue. Company’s EPS for the last quarter was -2.75.
Praxis Precision Medicines Inc – Insider Activity and Holdings
Investors get the exact data about the key infor mation of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 21.04 million. PRAX does have institutional investors; and they hold 114.66% of the stock.
As on 2024-06-30, BLACKROCK INC. was the top most holder in Praxis Precision Medicines Inc (NASDAQ:PRAX) with an ownership of 1.29 million shares of the company or 6.874 of the stake worth $53.52 million. The filing also reveals RA CAPITAL MANAGEMENT, L.P. as the second largest holder in the company with a control over 6.5638 of the outstanding shares. Its stake is worth $51.1 million for having 1.24 million shares in hand.
ADAGE CAPITAL PARTNERS GP, L.L.C. also came holding a key position in the company during the recent quarter and it now holds 6.0245 of the outstanding shares. With this there are now 204.0 institutions which have possession in PRAX’s shares.
Key Metrics for PRAX
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors befor e start trading into a stock. In recently reported quarter, Praxis Precision Medicines Inc has a debt to equity ratio of 0.00.
Technical Analysis of Praxis Precision Medicines Inc (NASDAQ:PRAX) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Praxis Precision Medicines Inc (PRAX), we notice that the stock’s 20-day average volume is at 490,465 shares and 50% of short term indicators are suggesting the stock as Sell. Its 50-day average volume of 442,846 shares. And to end, PRAX’s 100-day average volume is 416,289 shares with 50% of the long-term indicators pointing towards Sell for the stock.
